Co-head of Healthcare Ventures, John E Milad, appears on the Dealmaker's podcast

28/9/23
5 min
Healthcare
Insight
Download the report

Co-head of Healthcare Ventures, John E Milad, recently appeared on the Dealmaker's podcast, hosted by Alejandro Cremades.

John shared his insight on his remarkable journey – a trajectory that took him from a quaint small town to the bustling financial districts of major cities like Chicago, New York, and London. John's career in investment banking and venture capital has been characterised by an unquenchable thirst for knowledge and a dedication to revolutionizing the healthcare industry.

The Downing Healthcare Ventures team invests in tech-enabled healthcare companies that improve access to high-quality care, positively impact clinical outcomes and reduce the cost of delivery for patients worldwide.

Listen to the full podcast:

Find out more about John and the team

‍

Contents
See full contents

Co-head of Healthcare Ventures, John E Milad, recently appeared on the Dealmaker's podcast, hosted by Alejandro Cremades.

John shared his insight on his remarkable journey – a trajectory that took him from a quaint small town to the bustling financial districts of major cities like Chicago, New York, and London. John's career in investment banking and venture capital has been characterised by an unquenchable thirst for knowledge and a dedication to revolutionizing the healthcare industry.

The Downing Healthcare Ventures team invests in tech-enabled healthcare companies that improve access to high-quality care, positively impact clinical outcomes and reduce the cost of delivery for patients worldwide.

Listen to the full podcast:

Find out more about John and the team

‍

We are delighted to announce that Mark Gross, Partner and Head of Development Capital, has been named Equity Investor of the year at the HealthInvestor Power List 2024 Awards.

Following Mark’s achievement last year when he won the “Leading Investor” award at HealthInvestor’s Power50, this year’s win further highlights his continued success and expertise in investing across the healthcare sector. 

The judges praised Mark for finding success both in value and volume this year, delivering good returns and growth. They were impressed by how Mark has continued to strengthen a strong track record with further growth in the team and new funds securing further backing. We extend our thanks to Mark and the Downing Development Capital team for their continued dedication and support in expanding our healthcare investment activities with a focus on quality, performance and reputation. 

Congratulations Mark!

Development Capital  

Downing Development Capital is an award-winning investor focused on investment opportunities into asset-backed operating businesses with downside protection. Typical sectors they invest in include healthcare, specialist education, hospitality, leisure and IT infrastructure.

Learn more about our Development Capital team

‍

Co-head of Healthcare Ventures, John E Milad, recently appeared on the Dealmaker's podcast, hosted by Alejandro Cremades.

John shared his insight on his remarkable journey – a trajectory that took him from a quaint small town to the bustling financial districts of major cities like Chicago, New York, and London. John's career in investment banking and venture capital has been characterised by an unquenchable thirst for knowledge and a dedication to revolutionizing the healthcare industry.

The Downing Healthcare Ventures team invests in tech-enabled healthcare companies that improve access to high-quality care, positively impact clinical outcomes and reduce the cost of delivery for patients worldwide.

Listen to the full podcast:

Find out more about John and the team

‍

Basking in the sun: nine solar policy essentials
Learn more

Torsten Mack, Investment Director at Downing, said:

"We are proud to support this exceptional management team, whose strong track record positions them well to build a new business in dementia care. This needs-based sector is underpinned by a lack of quality supply and we are investing in Fortava Healthcare to set and deliver high standards, and to help make a difference."

Johann van Zyl, CEO at Fortava, added:

"I’m thrilled to be working with Jamie, as we share the same values. We plan to grow Fortava into a leading provider of dementia care over the next five to seven years. But growth isn’t our primary focus—our goal is to deliver outstanding care and foster a joyful, supportive environment for both residents and staff. We’re delighted to be partnering with Downing who also share our values and we look forward to this journey with them."

Jamie Stuart, CFO at Fortava, commented:

“For me, it's about being more than just another care home provider. While dementia care in the UK is generally of a good standard, we want to set ourselves apart with a fresh approach. That’s why, after over 25 years in banking, I chose to partner with Johann and Downing on this venture.”

‍

Co-head of Healthcare Ventures, John E Milad, recently appeared on the Dealmaker's podcast, hosted by Alejandro Cremades.

John shared his insight on his remarkable journey – a trajectory that took him from a quaint small town to the bustling financial districts of major cities like Chicago, New York, and London. John's career in investment banking and venture capital has been characterised by an unquenchable thirst for knowledge and a dedication to revolutionizing the healthcare industry.

The Downing Healthcare Ventures team invests in tech-enabled healthcare companies that improve access to high-quality care, positively impact clinical outcomes and reduce the cost of delivery for patients worldwide.

Listen to the full podcast:

Find out more about John and the team

‍

Please fill out the form to download the full report

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Sign up to stay up to date with the latest insights and investment opportunities
Learn more

Related Insights

View all

Co-head of Healthcare Ventures John E. Milad comments on the Mansion House reforms

18/7/2023
5 min
read
Learn more
Healthcare

Co-head of Healthcare Ventures John E. Milad comments on the Mansion House reforms

18/7/2023
5 min
read
Learn more
Healthcare

Co-Head of Downing Healthcare Ventures, John E Milad, speaks with Mark Klingsheim on the "Motivated to Lead" podcast

9/6/2023
5 min
read
Learn more
Healthcare

Co-Head of Downing Healthcare Ventures, John E Milad, speaks with Mark Klingsheim on the "Motivated to Lead" podcast

9/6/2023
5 min
read
Learn more
Healthcare
Stay up to date with 
our latest insights.
Sign up
Downing
HomeAboutResponsible investingInsightsTeamContact
Our investment areas
Renewable Energy & InfrastructurePrivate EquityPrivate Credit
Legal and support
Privacy and cookie policyTerms and conditionsModern slavery statements

Downing LLP does not provide advice or make personal recommendations and investors are strongly urged to seek independent advice before investing. Investments offered on this website carry a higher risk than many other types of investment and prospective investors should be aware that capital is at risk and the value of their investment may go down as well as up. Any investment should only be made on the basis of the relevant product literature and your attention is drawn to the risk, fees and taxation factors contained therein. Tax treatment depends on individual circumstances of each investor and may be subject to change in the future. Past performance is not a reliable indicator of future performance. Downing LLP is authorised and regulated by the Financial Conduct Authority (Firm Reference Number 545025). Registered in England No. OC341575. Registered Office: Downing, 10 Lower Thames Street, London, EC3R 6AF.

VAT Number: 112 940 149